Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial

Treatment of severe Coronavirus Disease 2019 (COVID-19) is challenging. We performed a phase 2 trial to assess the efficacy and safety of human umbilical cord-mesenchymal stem cells (UC-MSCs) to treat severe COVID-19 patients with lung damage, based on our phase 1 data. In this randomized, double-bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Lei, Huang, Hai, Lu, Xuechun, Yan, Xiaoyan, Jiang, Xiaojing, Xu, Ruonan, Wang, Siyu, Zhang, Chao, Yuan, Xin, Xu, Zhe, Huang, Lei, Fu, Jun-Liang, Li, Yuanyuan, Zhang, Yu, Yao, Wei-Qi, Liu, Tianyi, Song, Jinwen, Sun, Liangliang, Yang, Fan, Zhang, Xin, Zhang, Bo, Shi, Ming, Meng, Fanping, Song, Yanning, Yu, Yongpei, Wen, Jiqiu, Li, Qi, Mao, Qing, Maeurer, Markus, Zumla, Alimuddin, Yao, Chen, Xie, Wei-Fen, Wang, Fu-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873662/
https://www.ncbi.nlm.nih.gov/pubmed/33568628
http://dx.doi.org/10.1038/s41392-021-00488-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873662/
https://www.ncbi.nlm.nih.gov/pubmed/33568628
http://dx.doi.org/10.1038/s41392-021-00488-5

Ejemplares similares